4D Molecular Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: 4D Molecular Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: 4D Molecular Therapeutics Inc
Rating: 2.27725
Author: Trendlyne DVM scores

about

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic a...

8.73 0.04 (0.46%)

289.73% Gain from 52W Low

607.9K

XNAS Volume

XNAS 01 Oct, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

13.5 / 100

Technically Bullish

77.6 / 100

1Yr Price target upside is 274%

9 analysts

4D Molecular Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

4D Molecular Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic a...

289.73% Gain from 52W Low

SWOT Analysis

4D Molecular Therapeutics Inc Live Price Chart